Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03078868 · ClinicalTrials.gov registry record · NA
Utility of Diffusion-weighted MR Imaging
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03078868: Clinical Trial NA study, sponsored by University of Chicago.
NCT03078868 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03078868, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
To determine whether DW-MRI is applicable in the evaluation of post-operative collections, and whether utilization of DW-MRI can enhance application of percutaneous drainage and prevent unnecessary drainage.
Primary Outcome
Two radiologists will independently review the MR images for detection of collections. ADC maps will be generated for each patient. Each radiologist will assign a 1-5 point score based on the level of confidence in the diagnosis of abscess. These radiologists will then measure ADC of the collections in each patient on ADC maps. Mean and 10th percentile ADC values will be computed by placement of region of interest (ROI) on ADC maps using DW images as guide. Each ROI will be placed in the center
Interventions
- DEVICE Magnetic Resonance Scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2019-06-18 |
| Phase | NA |
Why NCT03078868 stopped before completion
NCT03078868 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Scanner is the first listed.
NCT03078868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03078868 about?
NCT03078868 is a clinical study titled "Utility of Diffusion-weighted MR Imaging". To determine whether DW-MRI is applicable in the evaluation of post-operative collections, and whether utilization of DW-MRI can enhance application of percutaneous drainage and prevent unnecessary drainage.
What is the current status of trial NCT03078868?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-02-15. Estimated completion is 2019-06-18.
What interventions are being tested in trial NCT03078868?
The interventions under investigation include: Magnetic Resonance Scanner (DEVICE).
Who is sponsoring clinical trial NCT03078868?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03078868's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI